Lyra Therapeutics Inc (NASDAQ: LYRA) is -19.28% lower on its value in year-to-date trading and has touched a low of $0.14 and a high of $6.79 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LYRA stock was last observed hovering at around $0.16 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.17, the stock is -10.61% and -12.38% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.03 million and changing 4.85% at the moment leaves the stock -31.39% off its SMA200. LYRA registered -97.11% loss for a year compared to 6-month loss of -40.07%. The firm has a 50-day simple moving average (SMA 50) of $0.1902 and a 200-day simple moving average (SMA200) of $0.24288.
The stock witnessed a -15.60% gain in the last 1 month and extending the period to 3 months gives it a -10.24%, and is -4.80% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.24% over the week and 8.17% over the month.
Lyra Therapeutics Inc (LYRA) has around 30 employees, a market worth around $10.98M and $1.53M in sales. Profit margin for the company is -6090.94%. Distance from 52-week low is 15.69% and -97.55% from its 52-week high. The company has generated returns on investments over the last 12 months (-223.25%).
with sales reaching $160k over the same period.The EPS is expected to grow by 42.42% this year, but quarterly earnings will post -43.92% year-over-year. Quarterly sales are estimated to shrink -69.92% in year-over-year returns.
76.0 institutions hold shares in Lyra Therapeutics Inc (LYRA), with institutional investors hold 51.16% of the company’s shares. The shares outstanding are 65.52M, and float is at 54.86M with Short Float at 3.42%. Institutions hold 50.86% of the Float.
The top institutional shareholder in the company is PERCEPTIVE ADVISORS LLC with over 12.76 million shares valued at $3.53 million. The investor’s holdings represent 19.4892 of the LYRA Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 4.77 million shares valued at $1.32 million to account for 7.2912 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 2.83 million shares representing 4.4211 and valued at over $0.78 million, while SAMSARA BIOCAPITAL, LLC holds 4.2473 of the shares totaling 2.78 million with a market value of $0.77 million.
